Metabasis swings axe on 43% of staff
This article was originally published in Scrip
Executive Summary
Metabasis Therapeuticsis to lay off more than 40% of its workforce in response to "tough market conditions". The San Diego operation will cut 38 jobs and narrow its focus to an early stage hyperlipidaemia candidate and a mid-stage diabetes treatment.